ES2757847T3 - Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria - Google Patents
Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria Download PDFInfo
- Publication number
- ES2757847T3 ES2757847T3 ES10783706T ES10783706T ES2757847T3 ES 2757847 T3 ES2757847 T3 ES 2757847T3 ES 10783706 T ES10783706 T ES 10783706T ES 10783706 T ES10783706 T ES 10783706T ES 2757847 T3 ES2757847 T3 ES 2757847T3
- Authority
- ES
- Spain
- Prior art keywords
- cuff
- pressure
- curve
- compliance
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 206010020565 Hyperaemia Diseases 0.000 title claims abstract description 32
- 208000022064 reactive hyperemia Diseases 0.000 title claims abstract description 20
- 230000000544 hyperemic effect Effects 0.000 claims abstract description 32
- 230000008859 change Effects 0.000 claims abstract description 24
- 230000007423 decrease Effects 0.000 claims abstract description 5
- 230000035488 systolic blood pressure Effects 0.000 claims description 8
- 238000012417 linear regression Methods 0.000 claims description 2
- 206010048554 Endothelial dysfunction Diseases 0.000 description 59
- 230000008694 endothelial dysfunction Effects 0.000 description 59
- 238000005259 measurement Methods 0.000 description 28
- 230000036772 blood pressure Effects 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 210000001367 artery Anatomy 0.000 description 12
- 201000011461 pre-eclampsia Diseases 0.000 description 12
- 238000001914 filtration Methods 0.000 description 11
- 208000024172 Cardiovascular disease Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000002093 peripheral effect Effects 0.000 description 10
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 201000001320 Atherosclerosis Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 230000004872 arterial blood pressure Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000000541 pulsatile effect Effects 0.000 description 4
- 208000019553 vascular disease Diseases 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 208000035150 Hypercholesterolemia Diseases 0.000 description 3
- 208000018262 Peripheral vascular disease Diseases 0.000 description 3
- 230000004219 arterial function Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000005242 cardiac chamber Anatomy 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000008753 endothelial function Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010040070 Septic Shock Diseases 0.000 description 2
- 230000008321 arterial blood flow Effects 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000007620 mathematical function Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010021138 Hypovolaemic shock Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02141—Details of apparatus construction, e.g. pump units or housings therefor, cuff pressurising systems, arrangements of fluid conduits or circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/0225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds
- A61B5/02255—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds the pressure being controlled by plethysmographic signals, e.g. derived from optical sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21336909P | 2009-06-02 | 2009-06-02 | |
| PCT/US2010/001605 WO2010141081A2 (en) | 2009-06-02 | 2010-06-02 | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2757847T3 true ES2757847T3 (es) | 2020-04-30 |
Family
ID=43221023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10783706T Active ES2757847T3 (es) | 2009-06-02 | 2010-06-02 | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria |
Country Status (8)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102481106A (zh) | 2009-06-02 | 2012-05-30 | 迈克尔·大卫·怀特 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
| US9788733B2 (en) | 2009-06-02 | 2017-10-17 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| US20180042490A1 (en) * | 2009-06-02 | 2018-02-15 | Cordex Systems, Inc | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| US20170000355A1 (en) | 2009-06-12 | 2017-01-05 | Everist Genomics, Inc. | System and method of assessing endothelial function |
| EP2704577A4 (en) * | 2011-05-05 | 2014-10-15 | Cedars Sinai Medical Center | EVALUATION OF A CORONARY HEART DISEASE WITH CARBON DIOXIDE |
| US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| US20140170069A1 (en) * | 2011-05-05 | 2014-06-19 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| RU2015143711A (ru) * | 2013-03-13 | 2017-04-28 | Эверист Геномикс, Инк. | Система и способ применения поток-опосредованной дилатации для определения скорректированного сосудистого возраста как показателя риска развития сердечно-сосудистого заболевания |
| US20150080747A1 (en) * | 2013-06-28 | 2015-03-19 | Cardiovascular Systems, Inc. | Devices, systems and methods for locally measuring biological conduit and/or lesion compliance, opposition force and inner diameter of a biological conduit |
| WO2015021078A1 (en) | 2013-08-05 | 2015-02-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury |
| WO2015134441A1 (en) * | 2014-03-03 | 2015-09-11 | Promedica Health System, Inc. | Systems and methods for performing an objective analysis of air plethysmography waveform |
| MX2016011715A (es) * | 2014-03-11 | 2017-04-27 | Cordex Systems Inc | Metodo y dispostivo para detectar y valorar hiperemia reactiva utilizando plestimografia segmentaria. |
| US10945612B2 (en) | 2014-04-03 | 2021-03-16 | The Regents Of The University Of California | Assessing endothelial function using a blood pressure cuff |
| CN106793963B (zh) * | 2014-08-28 | 2020-07-21 | 皇家飞利浦有限公司 | 用于振荡法无创血压(nibp)测量的方法和用于nibp装置的控制单元 |
| US10939832B2 (en) * | 2015-02-11 | 2021-03-09 | Microlife Intellectual Property Gmbh | Device and method for measuring blood pressure and for indication of the presence of atrial fibrillation |
| JP6482412B2 (ja) | 2015-07-01 | 2019-03-13 | 浜松ホトニクス株式会社 | 粘弾特性取得装置、粘弾特性取得方法、粘弾特性取得プログラム、及びそのプログラムを記録する記録媒体 |
| EP3334336B1 (en) | 2015-08-14 | 2024-01-17 | The Regents of The University of California | Assessing endothelial function and providing calibrated ufmd data using a blood pressure cuff |
| JP6831382B2 (ja) | 2015-12-23 | 2021-02-17 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 血圧測定の信頼性を評価する方法およびこれを実装する装置 |
| JP6627502B2 (ja) * | 2015-12-28 | 2020-01-08 | オムロンヘルスケア株式会社 | 電子血圧計 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4984577A (en) * | 1989-03-20 | 1991-01-15 | Hewlett-Packard Company | Oscillometric non-invasive method for measuring blood pressure and apparatus for automated oscillometric blood pressure measuring |
| US5417220A (en) * | 1989-12-20 | 1995-05-23 | Critikon, Inc. | Peripheral arterial monitoring instruments |
| WO1992022239A1 (en) * | 1991-06-12 | 1992-12-23 | Florida Atlantic University Research Corp. | Detecting atherosclerosis in humans |
| JPH06319707A (ja) * | 1993-05-13 | 1994-11-22 | Omron Corp | 電子血圧計 |
| US6309359B1 (en) * | 1998-06-01 | 2001-10-30 | Michael D. Whitt | Method and apparatus for noninvasive determination of peripheral arterial lumenal area |
| US6152881A (en) * | 1999-03-29 | 2000-11-28 | Vasocor, Inc. | Calibrated measurement of blood vessels and endothelium after reactive hyperemia and method therefor |
| US6338719B1 (en) * | 2000-06-12 | 2002-01-15 | Rutgers, The State University Of New Jersey | Method and system for detecting vascular conditions using an occlusive arm cuff plethysmograph |
| JP3393432B2 (ja) * | 2000-09-06 | 2003-04-07 | オムロン株式会社 | 電子血圧計 |
| CA2424389C (en) | 2000-10-23 | 2011-07-12 | Itamar Medical Ltd. | Method and apparatus for non-invasively evaluating endothelial activity in a patient |
| JP3590583B2 (ja) * | 2000-12-28 | 2004-11-17 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| JP2003284696A (ja) * | 2002-03-28 | 2003-10-07 | Omron Corp | 電子血圧計および電子血圧計の血圧測定方法 |
| US6733461B2 (en) * | 2002-08-01 | 2004-05-11 | Hypertension Diagnostics, Inc. | Methods and apparatus for measuring arterial compliance, improving pressure calibration, and computing flow from pressure data |
| US20070225614A1 (en) * | 2004-05-26 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
| US7390303B2 (en) * | 2003-09-30 | 2008-06-24 | Ehud Dafni | Assessment of vascular dilatation |
| WO2005069740A2 (en) * | 2004-01-27 | 2005-08-04 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
| JP4629430B2 (ja) * | 2004-12-28 | 2011-02-09 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| US8197416B1 (en) * | 2005-08-19 | 2012-06-12 | Ravi Shankar | Pulsatile measurement of cardiac malfunction conditions |
| US7674231B2 (en) * | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
| JP4144807B2 (ja) * | 2005-11-21 | 2008-09-03 | 株式会社志成データム | 血管硬化度測定装置および血圧測定装置 |
| RU2309668C1 (ru) * | 2006-02-20 | 2007-11-10 | Александр Сергеевич Парфенов | Способ неинвазивного определения функции эндотелия и устройство для его осуществления |
| JP5176020B2 (ja) * | 2007-03-02 | 2013-04-03 | 国立大学法人 名古屋工業大学 | 生体内管腔体評価装置 |
| JP2008272387A (ja) * | 2007-03-30 | 2008-11-13 | Hiroshima Univ | 血管粘弾性測定装置、血管粘弾性測定方法、プログラム、コンピュータ読み取り可能な記録媒体、大規模集積回路及びｆｐｇａ |
| JP5363795B2 (ja) | 2008-04-14 | 2013-12-11 | 国立大学法人広島大学 | 血管内皮機能評価装置及び血管内皮機能評価方法 |
| CN102481106A (zh) | 2009-06-02 | 2012-05-30 | 迈克尔·大卫·怀特 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
-
2010
- 2010-06-02 CN CN201080024509XA patent/CN102481106A/zh active Pending
- 2010-06-02 EP EP10783706.4A patent/EP2437656B1/en active Active
- 2010-06-02 CA CA2763890A patent/CA2763890C/en active Active
- 2010-06-02 US US12/792,504 patent/US8708921B2/en active Active
- 2010-06-02 CN CN201710123346.4A patent/CN107028601A/zh active Pending
- 2010-06-02 JP JP2012513936A patent/JP5689116B2/ja active Active
- 2010-06-02 WO PCT/US2010/001605 patent/WO2010141081A2/en active Application Filing
- 2010-06-02 AU AU2010257159A patent/AU2010257159B2/en active Active
- 2010-06-02 ES ES10783706T patent/ES2757847T3/es active Active
- 2010-06-02 CA CA2995279A patent/CA2995279C/en active Active
-
2014
- 2014-03-11 US US14/204,678 patent/US9668662B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010257159A1 (en) | 2012-01-19 |
| CA2763890C (en) | 2018-04-03 |
| EP2437656A2 (en) | 2012-04-11 |
| EP2437656A4 (en) | 2012-05-09 |
| CN102481106A (zh) | 2012-05-30 |
| US9668662B2 (en) | 2017-06-06 |
| US20100305459A1 (en) | 2010-12-02 |
| WO2010141081A3 (en) | 2011-03-24 |
| AU2010257159B2 (en) | 2015-03-26 |
| CN107028601A (zh) | 2017-08-11 |
| CA2995279C (en) | 2020-12-15 |
| US20140194754A1 (en) | 2014-07-10 |
| CA2763890A1 (en) | 2010-12-09 |
| JP5689116B2 (ja) | 2015-03-25 |
| JP2012528671A (ja) | 2012-11-15 |
| US8708921B2 (en) | 2014-04-29 |
| WO2010141081A2 (en) | 2010-12-09 |
| CA2995279A1 (en) | 2010-12-09 |
| EP2437656B1 (en) | 2019-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2757847T3 (es) | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria | |
| Poon et al. | Cuff-less and noninvasive measurements of arterial blood pressure by pulse transit time | |
| Chung et al. | Non-invasive continuous blood pressure monitoring: a review of current applications | |
| US10226186B2 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| US20030135124A1 (en) | Methods, apparatus and articles-of-manufacture for noninvasive measurement and monitoring of peripheral blood flow, perfusion, cardiac output biophysic stress and cardiovascular condition | |
| CN102469947B (zh) | 使用信号渡越时间来监控心血管状况 | |
| ES2715102T3 (es) | Método y dispositivo para diagnosticar el potencial de desarrollar una enfermedad cardiovascular | |
| ES2910070T3 (es) | Método y dispositivo para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria | |
| US20180042490A1 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| Balestrieri et al. | Calibration of automated non invasive blood pressure measurement devices | |
| AU2015202799A1 (en) | Method And Device For Detecting And Assessing Reactive Hyperemia Using Segmental Plethysmography | |
| Johnston et al. | Noninvasive measurement of systolic pressure slope: a reliable index of the presence of peripheral arterial occlusive disease | |
| Sadaghiani et al. | Validation of the Saadat NIBP module according to the ANSI/AAMI-SP10 protocol | |
| HK1243610A1 (en) | Method and device for assessing reactive hyperemia | |
| HK1235645A1 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| HK1235645B (zh) | 使用节段体积描记术检测和评估反应性充血的方法和装置 | |
| Rodríguez Árbol | Influencias simpáticas de la defensa cardiaca: Análisis de las variaciones fásicas en el periodo de pre-eyección |